TELA Bio (TELA) EBITDA (2018 - 2026)
TELA Bio's (TELA) quarterly EBITDA came in at -$10.5 million in Q1 2026, down 0.52% year-on-year from -$10.6 million in Q1 2025, and down 58.33% quarter-over-quarter from -$6.6 million in Q4 2025.
TELA Bio (TELA) EBITDA (2018 - 2026) Analysis & Trends
TELA Bio's EBITDA history runs 9 years deep, the most recent figure standing at -$10.5 million for Q1 2026.
- On a quarterly basis, EBITDA fell 0.52% year-over-year to -$10.5 million in Q1 2026; TTM through Mar 2026 was -$33.8 million, a 14.97% increase from a year earlier, with the FY2025 full-year figure at -$33.8 million, up 1.06% from the prior year.
- EBITDA slipped to -$10.5 million in Q1 2026 per TELA's latest filing, from -$6.6 million in the prior quarter.
- Across five years, EBITDA topped out at -$4.8 million in Q1 2024 and bottomed at -$12.3 million in Q4 2023.
- The 5-year median for EBITDA is -$9.8 million (2022), against an average of -$9.5 million.
- Across the five-year window, EBITDA surged 57.12% in 2024 and plunged 116.99% in 2025, its largest moves.
- Year by year, EBITDA stood at -$9.4 million in 2022, then tumbled by 30.08% to -$12.3 million in 2023, then surged by 31.96% to -$8.4 million in 2024, then advanced by 20.42% to -$6.6 million in 2025, then slumped by 58.33% to -$10.5 million in 2026.
- Per Business Quant, the three latest TELA EBITDA figures stand at -$10.5 million (Q1 2026), -$6.6 million (Q4 2025), and -$7.6 million (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 1.35 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 936.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 1.87 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 1.10 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 477.60 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 255.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 282.15 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 515.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | TELA Bio | 40.65 Mn | 1.11 Mn | 12.52 Mn | -10.53 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -10.53 Mn |
| Dec 31, 2025 | -6.65 Mn |
| Sep 30, 2025 | -7.55 Mn |
| Jun 30, 2025 | -9.08 Mn |
| Mar 31, 2025 | -10.47 Mn |
| Dec 31, 2024 | -8.35 Mn |
| Sep 30, 2024 | -9.37 Mn |
| Jun 30, 2024 | -11.57 Mn |
| Mar 31, 2024 | -4.83 Mn |
| Dec 31, 2023 | -12.28 Mn |
| Sep 30, 2023 | -10.18 Mn |
| Jun 30, 2023 | -10.36 Mn |
| Mar 31, 2023 | -11.25 Mn |
| Dec 31, 2022 | -9.44 Mn |
| Sep 30, 2022 | -9.49 Mn |
| Jun 30, 2022 | -10.24 Mn |
| Mar 31, 2022 | -9.84 Mn |
| Dec 31, 2021 | -7.65 Mn |
| Sep 30, 2021 | -7.22 Mn |
| Jun 30, 2021 | -7.31 Mn |